Author

S. Turcotte

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 3 Approach:experimental assay· 3 Organism:human· 3 Research Focus:drug response / drug discovery· 2 Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1

Frequent Co-Authors

C. M. Rive· 1 shared C. S. Hughes· 1 shared C. Warren· 1 shared D. Comeau· 1 shared D. F. Schaeffer· 1 shared D. J. Renouf· 1 shared D. T. Yapp· 1 shared D. Tchelouggou· 1 shared

Activity by Year

2018-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 22 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

C. M. Rive

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Defining melanoma combination therapies that provide senolytic sensitivity in human melanoma cells

D. Tchelouggou, N. Malaquin, G. B. Cardin, J. Desmul, S. Turcotte, F. Rodier

This study identifies combination therapies for melanoma that enhance senolytic sensitivity by analyzing senescence responses to different treatments.

bioRxiv · Oct 1, 2023Cancer Biology

Recombinant T cell receptors specific for HLA-A*02:01-restricted neoepitopes containing KRAS codon 12 hotspot mutations

C. M. Rive, E. Yung, C. S. Hughes, S. D. Brown, G. Sharma, L. Dreolini, N. M. Mawji, C. Warren, J. Karasinska, J. M. Loree, D. T. Yapp, G. B. Morin, D. J. Renouf, D. F. Schaeffer, S. Turcotte, R. A. Holt

The paper identifies and characterizes T cell receptors specific for HLA-A*02:01-restricted KRAS codon 12 mutations in cancer, showing their reactivity and cytotoxic activity against tumor cells.

bioRxiv · Jun 15, 2020 · PreprintImmunology

STF-62247 blocks late stages of autophagy by disrupting lysosomal physiology

N. Bouhamdani, D. Comeau, K. Cormier, S. Turcotte

This paper shows STF-62247 blocks late autophagy by disrupting lysosomal function in VHL-mutated cells.

bioRxiv · Apr 10, 2018Cancer Biology